Source - SMW
Are you a stock market investor looking for fresh investment ideas?  If you are, then why not come and join Shares and AJ Bell Media at their evening event in London on Tuesday 11 July 2017 and meet the directors from Metal NRG (NEX.MNRG), Midatech Pharma (MTPH) and Sphere Medical (SPHR) and Xpediator.

During the event and afterwards over drinks, investors will have the chance to listen to presentations from each of the companies and talk directly to the company directors about their plans and vision for their businesses.

MetalNRG (NEX.MNRG) - MetalNRG is an NEX Exchange quoted natural resource investing company seeking investments in precious and strategic metals. MetalNRG is reviewing opportunities in various commodities and jurisdictions and anticipates updating the market shortly with regard to its initial target investments. It recently announced its first investing step with the creation of the Palomino Cobalt Project in Western Australia. MetalNRG's CEO, the well-known resources entrepreneur Paul Johnson (ex-CEO of Metal Tiger), will provide an update on the company's investment strategy.

Other companies presenting include:

Midatech Pharma (MTPH) -  Midatech has a balanced portfolio of fast-growth marketed oncology products and development programmes for its own products, using its proprietary platform technologies to target diseases with unmet medical need.  Midatech offers the potential for rapid revenue growth through its differentiated product portfolio and exciting development pipeline, supported by strong IP and, an ambitious and highly experienced leadership team.

Sphere Medical (SPHR) - Sphere Medical's vision is to become a leading solution provider to the critical care market offering innovative, frequent on demand, point of care diagnostic and monitoring products to enable closer control of therapeutic response, improve patient outcomes and reduce the overall cost of care. The Company's strategy is focused on the Proxima platform for measuring blood gases, electrolytes and metabolites. The latest generation of the product, Proxima 4, was launched in December 2016 and is being marketed directly to the critical care market in the UK, Germany, The Netherlands and Belgium, and by distributors in Italy and Spain. 

Xpediator (IPO due on AIM July 2017) - Xpediator Plc is expected to IPO on the London Stock Exchange's AIM market in July 2017. It is a well-established international provider of freight management services operating across the UK and Europe with a particular focus on, and expertise in, the CEE markets. The Group currently employs over 600 people with its operational headquarters in Braintree, England, and country offices in Bulgaria, Lithuania, Estonia, Macedonia, Montenegro, Moldova, Romania and Serbia operating from 22 sites in total.



Paul Johnson, CEO - MetalNRG (MNRG)

Dr Jim Phillips, CEO - Midatech Pharma (MTPH)

Dr Wolfgang Rencken, CEO - Sphere Medical (SPHR)

Stephen Blyth, CEO - Xpediator

Sponsored by:   AJ Bell Youinvest

PrimaryBid   Shareholders and potential investors can register now for free at: